BIOPHYTIS (ALBPS.PA) Stock Income Statement
EPA:ALBPS - Euronext Paris - Matif - FR001400OLP5 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | 0.00 | 1.00K | 0.00 | |||
| Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 12.20M | 14.33M | 23.27M | 26.82M | 13.94M | |||
| Research and Development | 8.60M | 10.41M | 19.45M | 24.00M | 13.26M | |||
| Selling, General, and Administrative Expenses | 1.48M | 1.57M | 4.11M | 3.11M | 1.80M | |||
| Operating Income | -12.20M | -14.33M | -23.27M | -26.82M | -13.94M | |||
| Interest Income/Expense | -2.12M | -2.15M | 23.00K | -2.38M | -11.57M | |||
| Other Income/Expense | -760.00K | -538.00K | -967.00K | -1.97M | N/A | |||
| Income Before Taxes | -15.08M | -17.03M | -24.22M | -31.16M | -25.52M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Net Income | -15.07M | -17.03M | -24.22M | -31.16M | -25.52M | |||
| EBITDA | -11.51M | -13.53M | -22.79M | -26.50M | -13.66M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -6.54 | -12.54 | -55.40 | -105.39 | -0.43 | |||
| Statistics | ||||||||
All data in EUR